Oct 06, 2023, 11:30

Carbiotix (publ) ("Carbiotix" or "Company") announces today that the Company's CEO, Erik Deaner, has purchased 138,220 shares at a total value of 97,957 SEK. Furthermore, the Company's chairman, Kristofer Cook, has purchased 124,361 shares at a total value of 87,115 SEK through his holding company Sustainable Holding Sweden AB.

Carbiotix CEO Erik Deaner acquired a total of 138,220 shares on October 4, 2023, at an average price of 0,71 kronor per share. Before this acquisition, Erik Deaner's total ownership amounted to 44,612 shares, corresponding to approximately 0.22 percent. After the acquisition, the holding amounts to 182,832 shares, corresponding to approximately 0.88 percent of the votes and capital in the Company.

On October 5, the Company's chairman, Kristofer Cook, also purchased a total of 124,361 shares at an average price of 0,7 kronor per share through his holding company Sustainable Holding Sweden AB. Before this acquisition, Kristofer Cook's total holdings amounted to 3,875,639 shares, corresponding to 18.69 percent. After the acquisition, the holding amounts to 4,000,000 shares, corresponding to approximately 19.28 percent of the votes and capital in the Company.

All transactions were carried out in ongoing trading.

Erik Deaner, CEO of Carbiotix, comments
"I have chosen to increase my holdings in Carbiotix because I strongly believe in the Company's future. My confidence is based on the growing interest in LinkGut, our gut health testing service, and the commercialization of our first CarbiAXOS product. I have great faith in our dedicated team, which is why I have chosen to quadruple my previous holdings.”

Forward-looking statements
This communication contains forward-looking statements, consisting of subjective assumptions and forecasts for future scenarios. Predictions for the future only apply as of the date they are made and are, by their nature, as is research and development work in the biotechnology segment, associated with risk and uncertainty. With this in mind, the actual outcome may deviate significantly from the scenarios as described in this press release.

För mer information:
Carbiotix AB
Erik Deaner, VD
Tel: 0738-673085
E-mail: erik.deaner@carbiotix.com

Carbiotix AB (CRBX) (www.carbiotix.com) is an award-winning biotechnology company pioneering microbiome healthcare through a portfolio of prebiotic modulators and diagnostic testing services.

Go Back